A panel of biomarkers would, thus, seem to be more useful for the early detection of AKI [27], although we could not demonstrate the advantage of assessing both L-FABP and NGAL, because the time points at which each of these biomarkers peaked were different. Here, LCN2 is linked to acute kidney injury.